3
Announcements
Trials
Browse
Landscape
Status
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
39
Observational
1
Expanded_access
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Polycythemia Vera
2
Primary Myelofibrosis
1
Interventions
venetoclax
1
selinexor
1
ruxolitinib
1
navitoclax
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
Primary Myelofibrosis
×
ruxolitinib
×
Clear all
NCT04745637
2025-11-18
Managed Access Programs for INC424, Ruxolitinib
Novartis
Available